GVAX Plus Checkpoint Blockade in Neuroblastoma
Clinical trial NCT04239040 · TERMINATED
Trial details
- NCT number
- NCT04239040
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2024-01-27
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.